Zobrazeno 1 - 10
of 29
pro vyhledávání: '"V. V. Brzheskiy"'
Autor:
E. A. Drozdova, S. Yu. Golubev, V. V. Brzheskiy, E. A. Romanova, V. A. Kireeva, E. V. Berdnikova
Publikováno v:
Oftalʹmologiâ, Vol 20, Iss 1, Pp 165-171 (2023)
It is considered, that one of the main directions of treatment of adenovirus conjunctivitis is the appointment of interferon alpha-2b in combination with diphenhydramine, which until recently was provided by the only original drug. In 2020, the first
Externí odkaz:
https://doaj.org/article/9f8bdfa6bcc544cd9620e18c50f8a6ea
Publikováno v:
Российский офтальмологический журнал, Vol 15, Iss 1, Pp 113-116 (2022)
Inherited retinal dystrophies (IRD) include a wide range of genetically and phenotypically heterogeneous diseases that lead to progressive loss of vision. With the development of gene therapy, it has become possible to treat two forms of IRD caused b
Externí odkaz:
https://doaj.org/article/9882c44ac4f347f0bf3f0ca1f95b6297
Autor:
E. L. Efimova, V. V. Brzheskiy
Publikováno v:
Oftalʹmologiâ, Vol 18, Iss 4, Pp 932-937 (2021)
The problem of drug therapy for bacterial eye infections in children has remained relevant for many years. The greatest interest of ophthalmologists in recent years is associated with the use of fluoroquinolones in the treatment of inflammatory eye d
Externí odkaz:
https://doaj.org/article/1cbe0f48a03b432a951d1671ee18c040
Publikováno v:
Oftalʹmologiâ, Vol 18, Iss 1, Pp 129-135 (2021)
The aim of the study was to evaluate the effectiveness of the preparations Optinol® Express Moisture (0.21 %) and Optinol® Deep Moisture (0.4 %) in the treatment of children with dry eye syndrome (DES) and to determine the indications for prescribi
Externí odkaz:
https://doaj.org/article/fd45be134e2649c988e5bad4a630c30e
Autor:
V. V. Brzheskiy, S. Yu. Golubev, O. I. Lebedev, E. S. Milyudin, A. S. Apostolova, A. V. Surov, E. L. Efimova, E. V. Varlashina, I. N. Gorbachevskaya, V. O. Kirichenko
Publikováno v:
Oftalʹmologiâ, Vol 17, Iss 3, Pp 481-489 (2020)
The purpose: to evaluate the effectiveness of the Delfanto® in the complex therapy of patients with dry eye syndrome of various etiologies and severity of the clinical course.Patients and methods. 114 patients (228 eyes) with dry eye syndrome of var
Externí odkaz:
https://doaj.org/article/5213142c20a74f4eae2e8f45597fdf13
Publikováno v:
Oftalʹmologiâ, Vol 16, Iss 2, Pp 244-251 (2019)
The artificial tears on the basis hyaluronic acid is primary importance today in dry eye syndrome (DES) treatment. In recent years, they have been supplemented Optinol® Express Moisture (0.21 %) and Optinol® Deep Moisture (0.4 %) differing concentr
Externí odkaz:
https://doaj.org/article/527797bc987e4c6ebcaf59a6029c39cc
Publikováno v:
Oftalʹmologiâ, Vol 16, Iss 1, Pp 56-62 (2019)
The problems of resistance to modern antibiotics and fluoroquinolones naturally stimulate interest in the development of eye dosage forms based on antiseptics. Today, their list has successfully supplemented the domestic drug Okomistin eye, ear, nasa
Externí odkaz:
https://doaj.org/article/66647c7cae034d6fb30c9b0800ec45f8
Autor:
V. V. Brzheskiy
Publikováno v:
Российский офтальмологический журнал, Vol 10, Iss 4, Pp 74-81 (2018)
The importance of vernal keratoconjunctivitis (vernal conjunctivitis, or vernal catarrh) is not so much due to its level of prevalence (today its occurrence amounts to 1.25-11.29 per 10 000 population of European countries), but rather to the severit
Externí odkaz:
https://doaj.org/article/86af72f3766f45dbbfab7a31afbb7902
Autor:
V. V. Brzheskiy, I. V. Kalinina
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 120-125 (2015)
In recent years, dry eye syndrome has attracted an increasing attention from ophthalmologists all over the world. This is largely due to the prevalence of the disease: the average number of people suffering from the disease is 14--15% of the adult po
Externí odkaz:
https://doaj.org/article/1bfae8d27b6b4cb7b626dc05f92a525f
Publikováno v:
Oftalʹmologiâ, Vol 9, Iss 1, Pp 83-91 (2014)
Purpose: Investigation of microflora of conjunctiva and its resistance to antibacterial drugs in healthy children and patients with various inflammatory eye diseases.Methods: We examined 402 children (421 eyes) in the age from 1 month till 17 years:
Externí odkaz:
https://doaj.org/article/7958ad967e4a48d19157bd03a6e781fe